Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization

Advanced Instruments, LLC

PR91053

 

NORWOOD, Mass., Aug. 6, 2021 /PRNewswire=KYODO JBN/ --

 

Advanced Instruments, a leading manufacturer of analytical instruments and

services for bioprocessing, today announced the execution of a definitive

agreement to acquire Solentim, a trusted global leader of solutions for the

isolation and characterization of high value single cell clones in cell line

development (CLD) applications. The acquisition expands both companies'

positions in the bioprocess workflows for advanced therapies.

 

Logo -

https://mma.prnewswire.com/media/1588715/AI_Logo_Blue_Screen_Master_RGB.jpg

 

Advanced Instruments' OsmoTECH(R) portfolio of osmometers, designed

specifically for the biopharm industry, are a powerful tool to characterize and

optimize cell culture conditions to support clonal growth and selection as well

as support upstream and downstream production processes. The Solentim products

are utilized in the early stages of biologic drug development to accelerate the

selection of optimal clones for production of monoclonal antibodies, gene

therapies and iPSC derived cell therapies. Advanced Instruments' and Solentim's

technologies are synergistic, drive efficiencies, and support improved clonal

lines for use in therapeutic workflows.

 

"The addition of Solentim aligns with our core strategy to invest in leading

technologies that deliver significant customer value across different segments

in monoclonal antibody and cell and gene therapies," commented Byron Selman,

President & CEO of Advanced Instruments. "The coming together of Advanced

Instruments' and Solentim's core technologies, will be a powerful combination

in support of clonal cell line development. With Solentim, we are acquiring

innovative technologies that will enhance our ability to support customers in

these workflows. We are also adding to our technical capabilities with the

addition of imaging, advanced AI capabilities and automation expertise that

will allow us to continue to expand on the innovative solutions that we

deliver."

 

Solentim is based in Bournemouth, UK, with additional sites that serve

customers in the United States, Europe, and Asia Pacific. This network supports

the Advanced Instruments global footprint and expands our ability to support

our ever-growing, combined customer base. The addition will also bring together

two well-known brands with organizations that have strong commitments to their

customers by providing world class scientific and customer support

organizations.

 

"We are excited about joining the Advanced Instruments team," said Mark

Truesdale, Chief Executive Officer of Solentim. "Our companies share many

similar goals including a vision for sustained innovation, a strong connection

to the customer globally and a desire to provide solutions that drive

efficiency and deliver value in the development of life-sustaining therapies.

The combination of our technologies and commercial footprint will support our

shared vision for accelerated growth."

 

"We look forward to Solentim joining the Advanced Instruments and Patricia

Industries family and continuing on the next phase of growth together," said

Yuriy Prilutskiy, Head of Patricia Industries North America, a part of Investor

AB, and owner of Advanced Instruments. "Patricia Industries is committed to

supporting the combined Advanced Instruments and Solentim teams in their

mission to deliver solutions that accelerate and improve the development of

biopharmaceuticals globally, and we are excited to accelerate investment in

their combined commercial and R&D capabilities. This transaction leverages

Patricia Industries' healthcare and life sciences expertise and aligns with our

purpose of creating value for people and society by building strong and

sustainable businesses."

 

Advanced Instruments was represented by Rothschild & Co (financial advisor) and

Simpson Thacher & Bartlett LLP (legal advisor).

 

Solentim was represented by EC M&A (financial advisor) and Ernst & Young LLP

(legal, financial, and tax advisor).

 

For Further Information:

Advanced Instruments

Contact: Lisa Fahey

781-471-2106

 

Solentim

Contact: Mark Truesdale

+44 1202 798510

 

About Advanced Instruments

 

Advanced Instruments is a global provider of scientific and analytical

instruments for the biotechnology, clinical, and food and beverage industries.

For more than 65 years, the company's innovations have helped organizations

improve quality of results, achieve reliable outcomes, and increase workplace

productivity. Advanced Instruments has a diverse portfolio of products,

including freezing point osmometers, cerebrospinal fluid cell counters,

anaerobic jar systems, cryoscopes, pasteurization test systems, and testing

standards and controls. For more information, visit www.aicompanies.com

 

About Solentim

 

Solentim (https://c212.net/c/link/?t=0&l=en&o=3249941-1&h=1232017778&u=https%3A%2F%2Fwww.solentim.com%2F&a=Solentim) is the trusted global leader in workflows for antibody and cell-based

therapies. Our assurance rich technologies enable the isolation, growth and

characterization of high value cells while our data driven platform enables

smarter decision earlier in the process. Together, our customers experience

faster workflows, confidently designed for regulatory environments.

 

About Patricia Industries

 

Patricia Industries, a part of Investor AB, makes control investments in

best-in-class companies with strong market positions, brands and corporate

cultures within industries positioned for secular growth. Our ambition is to be

the sole owner of our companies, together with strong management teams and

boards. We invest with an indefinite holding period and focus on building

durable value and capturing organic and non-organic growth opportunities.

 

About Investor AB

 

Investor, founded by the Wallenberg family in 1916, is an engaged owner of

high-quality, global companies. We have a long-term investment perspective.

Through board participation, as well as industrial experience, our network and

financial strength, we work continuously to support our companies to remain or

become best-in-class. Our holdings include among others ABB, Atlas Copco,

Ericsson, Molnlycke and SEB. For more information, visit www.investorab.com.

 

SOURCE Advanced Instruments, LLC

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中